erythrosine has been researched along with Cerebral Amyloid Angiopathy in 1 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Cerebral Amyloid Angiopathy: A heterogeneous group of sporadic or familial disorders characterized by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES. Clinical features include multiple, small lobar CEREBRAL HEMORRHAGE; cerebral ischemia (BRAIN ISCHEMIA); and CEREBRAL INFARCTION. Cerebral amyloid angiopathy is unrelated to generalized AMYLOIDOSIS. Amyloidogenic peptides in this condition are nearly always the same ones found in ALZHEIMER DISEASE. (from Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prior, R | 1 |
| D'Urso, D | 1 |
| Frank, R | 1 |
| Prikulis, I | 1 |
| Pavlakovic, G | 1 |
1 other study available for erythrosine and Cerebral Amyloid Angiopathy
| Article | Year |
|---|---|
Loss of vessel wall viability in cerebral amyloid angiopathy.
Topics: Animals; Cerebral Amyloid Angiopathy; Cerebral Arteries; Dogs; Fluoresceins; Fluorescent Antibody Te | 1996 |